EN DE

Ihuman Inc (IH) Fair Value & Analysis

Consumer Defensive · US · Market cap $70.5M · ISIN US45175B1098

What is Ihuman Inc really worth?

II Ihuman Inc logo Ihuman Inc IH · US
Price$1.22
Fair Value$1.14
Upside−6.5%
Quality60/100

A solid business, currently priced close to our fair value of $1.14.

Watch Ihuman Inc for free, get notified when fair value or trend changes. Plus fair value for all 35,000+ stocks, 14 days of Pro free, no card. Watch for free

Strengths

✓Solidly profitable · 11.8% net margin
✓generates free cash flow
✓Ranks above peers (6/10)

Risks

!Mixed Growth (revenue 5y +33.4 %/yr)
!Narrow moat 38/100
!Evidence only medium, so the estimate is less certain
!Weak on valuation: 25 out of 100

For context

·4.31% dividend yield
Evidence: Medium Range $0.8828 – $1.27

Fair value as of: Aug 30, 2026

From 26 valuation models · updated 2 days ago

Fair value updated Aug 30, 2026, revised from $1.10 to $1.14 (+3.3%) since Aug 27, 2026. Share price −9.6% over the past month.

What runs behind every stock

26 valuation models 8 families, DCF to NCAV 37 quality factors margins, balance sheet, cashflow, debt 6 AI factors moat, what no ratio measures 2,000+ data points verified, per stock, median

69 individual criteria per stock, every one traceable See the method →

What matters now

  • The price sits close to our fair value, market and models broadly agree here, little valuation tension.
  • The price sits in the upper half of our model range, so the margin of safety is thin.
  • Read the verdict with care: some models are missing inputs, so the estimate scatters more than usual.

Price vs Fair Value (5 years)

$9.53 $1.02 Fair Value $1.14 May 2021 Aug 2026

White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Aug 30, 2026.

How to read this chart

60‑month range $1.02 – $9.53 · fair‑value band $0.8828 – $1.27 · the $1.22 price screens above the $1.14 fair value. Dashed = 300-day average. As of Aug 30, 2026.

Full chart & analysis →

Which stocks are undervalued right now? Check free Discover now →

Analysis

Ihuman Inc (IH) currently trades at $1.22, while our model-based Fair Value estimate is $1.14, implying the stock looks roughly 6.9% fairly valued today. The Quality Score stands at 60/100 (solid quality), in the Consumer Defensive sector. Bull case: the DCF Models group reads highest at a median of $1.14 per share, and 5 of the 26 models we run sit above the $1.22 price. Bear case: the Dividend Discount group reads lowest at $0.2365, and 21 of the 26 models stay below the price. Evidence for this calculation is medium.

Over the trailing twelve months, Ihuman Inc generated revenue of $807M at a net margin of 11.8%. Revenue declined 18.1% year over year. It earns a return on equity of 9.8%. The balance sheet holds a net cash position of $1.1B. Fundamentals as of Aug 30, 2026

Our scenario range runs from $0.8828 (bear case) to $1.27 (bull case); at $1.22, the current price sits within that range. Bear and bull are the same models run on conservative and optimistic assumptions (margins, growth, valuation multiples), so a plausible valuation range, not a price target. The share trades about 64% below its 52-week high, currently below its 200-day average. For context, the median of 10 Consumer Defensive peers we cover trades at 8% fair-value upside, at −6%, IH screens richer than that median.

Fair Value models

This estimate rests on fiscal year 2025 figures, and about 8 months have passed since. In that time the company retained roughly $0.1805 per share, which is 15.8 % of the fair value. The fair value deliberately does not add this in: the models value reported figures, not a projection.

Each model estimates fair value its own way; the Fair Value above is the evidence-weighted, family-balanced blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small. Every input is real reported data, nothing guessed.

Model Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. Evidence
Highest evidence
FCF DCF best evidence $0.8760 $0.9966 $1.16 78
Growth DCF $0.8731 $0.9793 $1.12 75
Residual Income $0.4385 $0.4651 $0.5012 74
All 26 models by family
DCF Models
FCF DCF best evidence $0.8760 $0.9966 $1.16 78
Owner Earnings $1.15 $1.41 $1.77 73
5Y Revenue Exit $0.9342 $1.14 $1.42 69
5Y EBITDA Exit $0.9400 $1.15 $1.41 72
5Y P/E Exit $1.21 $1.68 $2.22 67
10Y Revenue Exit $0.8968 $1.06 $1.31 64
10Y EBITDA Exit $0.9082 $1.07 $1.31 65
10Y P/E Exit $1.06 $1.40 $1.87 60
Earnings-Based
Graham-Dodd $0.3648 $1.52 $2.08 62
Lynch FV $0.3862 $0.5515 $0.7169 59
PEG = 1.0 $0.3862 $0.5515 $0.7169 55
EPV $0.8890 $0.9179 $0.9417 70
Dividend Discount
Gordon GGM $0.1488 $0.2495 $0.3238 66
DDM Multi-Stage $0.1488 $0.2365 $0.2683 65
Multiples
P/E Multiple $0.8851 $1.18 $1.48 63
P/S Multiple $0.4083 $0.5447 $0.6808 58
P/B Multiple $0.6841 $0.9121 $1.14 55
EV/EBIT $1.15 $1.32 $1.49 63
EV/EBITDA $1.02 $1.15 $1.28 64
EV/Revenue $0.9894 $1.14 $1.28 52
Asset-Based
NCAV (Graham) $0.2800 $0.3752 $0.5600 51
Growth DCF
Growth DCF $0.8731 $0.9793 $1.12 75
Rev-Margin DCF $0.9342 $1.14 $1.39 69
Economic Profit
Residual Income $0.4385 $0.4651 $0.5012 74
ROIC Compounder $0.8890 $0.9179 $0.9417 68
Growth Earnings
Growth-Adj P/E $0.6763 $0.9663 $1.26 65

Widest divergence: DCF Models ($1.14) versus Dividend Discount ($0.2365). Highest evidence: FCF DCF (78).

Notify me when IH reaches fair value

Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click.

Key figures & financial health

P/E ratio 5.1 as of Jun 21, 2026
P/S ratio 0.60 P/E × margin
EPS (TTM) $0.2700 price ÷ EPS = P/E 5.1
Dividend yield 4.3% payout 19.5%
Net margin 11.8% FY2025
Return on equity 9.8% TTM
More key figures
Profitability
Return on assets (EBIT) 4.9% avg 5y
Operating margin 4.7% TTM
Growth
Revenue (TTM) $807M TTM
Revenue growth (YoY) −18.1% 3y avg −6.4%
EPS growth (YoY) −33.5%
Balance sheet & cash flow
Free cash flow $45.1M FY2025
Net cash $1.1B FY2025

Figures from reported company fundamentals · as of Aug 30, 2026. TTM = trailing twelve months.

Quality Score breakdown

Overall quality 60/100

Of which business quality 59 · Market factors (momentum, volatility) 20

Profitability 52
Margins and returns on capital today
Quality Growth 31
Are margins and returns improving?
Cashflow 40
Earnings quality: real cash, not paper profit
Fin. Strength 71
Balance sheet, leverage, solvency risk
Investment 84
Disciplined investing over empire-building
Low Volatility 56
Calm price path (market factor)
Momentum 8
Price trend over the last 3–12 months (market factor)
52W Momentum 0
Distance to the 52-week high (market factor)
Net Issuance 90
Buybacks instead of dilution

Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.

All values are scores from 0 to 100 (100 = best against fixed, research-based bands), not percentages. The three market factors (momentum, 52-week proximity, low volatility) are displayed but carry zero weight in the headline number: market sentiment is not a business property.

About the company

iHuman Inc., together with its subsidiaries, provides an integrated suite of tech-powered intellectual development products to individual users, kindergartens, and distributors in the People's Republic of China.

Full company description

iHuman Inc., together with its subsidiaries, provides an integrated suite of tech-powered intellectual development products to individual users, kindergartens, and distributors in the People's Republic of China. The company offers interactive and self-directed apps, including iHuman Chinese, iHuman English, iHuman Pinyin, iHuman Math, iHuman Books, iHuman Stories, iHuman Chinese Classics, iHumanpedia, iHuman Kids Workout, iHuman Coding, iHuman Fun Idioms, iHuman Little Artists, iHuman Readers, iHuman Writing, iHuman Fantastic Friends, iHuman AI Coding, and FreeTalk; bekids Coding, bekids Coloring, bekids Reading, bekids Puzzle, bekids Academy, bekids Library, and the Gogo series; Reading Stars; and Aha World and Aha Makeover. It also provides offline products, such as iHuman AI Pal, a plush AI companion; and the iHuman AI Bilingual Early Learning Tablet, an AI-powered smart learning tablet that delivers a bilingual Chinese-English content library for children. In addition, the company offers intellectually stimulating materials, including books, interactive materials, and smart devices that develop children's abilities in speaking, critical thinking, independent reading, and creativity. Further, it engages in the operation of online applications; provision of management and technical consulting; and research and development activities. iHuman Inc. was founded in 1996 and is based in Beijing, the People's Republic of China.

Company description, as reported by the company or data provider.

Revenue & earnings trend

FY2021 – FY2025 · reported fiscal years

Ihuman Inc reported revenue of $807M in FY2025 versus $945M in FY2021, a compound −3.9%/yr. Reported net income was $95.4M in FY2025.

Growth Quality 81/100
Revenue is growing, but margins or cash flow do not fully confirm the trend.
Latest Revenue (FY 2025)
$807M
Avg. revenue growth/yr (3Y) ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump.
−0.8%
Avg. revenue growth/yr (5Y) ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump.
+33.4%
Avg. revenue growth/yr (6Y) ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump.
+38.3%
Value creation/yr (3Y) ⓘEarnings growth per share (CAGR 3 years) plus dividend yield: value created per share and year.
−8.3% (−12.6 + 4.3)
Revenue −3.9%/yr
FY21 $945M
FY22 $986M
FY23 $1.0B
FY24 $922M
FY25 $807M
Net income
FY21 −$37.1M
FY22 $110M
FY23 $181M
FY24 $98.6M
FY25 $95.4M

Watch IH: get an alert when its fair value changes →

Run the numbers yourself: free valuation calculators
DCF CalculatorGraham NumberPeter Lynch FormulaDDM CalculatorFama-French ModelIntrinsic Value
Share or link this analysis
𝕏 Post WhatsApp LinkedIn Reddit
For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Ihuman Inc · Fair Value
$1.14 −7%Fair Value
Calculator →

Cite: Fair Value Calculator (2026). "Ihuman Inc Fair Value". https://www.fairvalue-calculator.com/stock/IH

Peer Group

Education & Training Services · 150 stocks

How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.

Quality Score 60 · Above median
Fair Value upside −9% · Below median
Return on equity (TTM) 10% · Above median
Return on assets 3% · Below median
Net margin (TTM) 12% · Above median
Operating margin (TTM) 5% · Below median
Revenue growth −18% · Bottom 25%
Dividend yield (TTM) 4.3% · Above median

Valuation Multiples vs Education & Training Services median · lower = cheaper

P/E (TTM) 5.1× · Cheaper than 75% of peers
P/FCF 1.6× · Cheaper than median

Strength profile in five axes (Snowflake)

Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.

VALUEFUTUREPASTHEALTHDIVIDEND
This stock
VALUEFUTUREPASTHEALTHDIVIDEND
Sector peers
VALUE25 · sector 33
FUTURE0 · sector 24
PAST39 · sector 18
HEALTH0 · sector 95
DIVIDEND86 · sector 65

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

Similar stocks

10 more Education & Training Services stocks, each showing price versus our Fair Value estimate (as of Aug 30, 2026).

Stock Price Fair Value vs Fair Value
New Oriental Education & Technology Group EDU $57.72 $48.37 −16%
TAL Education Group TAL $11.69 $15.60 +33%
Laureate Education, Inc LAUR $38.36 $41.45 +8%
Physicswallah Limited PWL ₹119.46 ₹13.69 −89%
Grand Canyon Education, Inc LOPE $151.19 $152.01 +1%
Covista Inc CVSA $128.22 $135.45 +6%
Stride, Inc LRN $84.58 $139.45 +65%
Universal Technical Institute, Inc UTI $25.64 $20.98 −18%
Perdoceo Education Corporation PRDO $33.81 $40.65 +20%
Strategic Education, Inc STRA $85.31 $105.48 +24%

Compare Ihuman Inc with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Explore undervalued stocks

More undervalued Consumer Defensive stocks →

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued Blue-Chip StocksUndervalued Small-Cap StocksUndervalued Dividend Stocks

Try a ready-made strategy

Pick a strategy and jump into the live analysis with that exact screen applied.

🥇 Backtested Best 🏆 Big Names ⭐ Top Rated 💎 Quality on Sale 🚀 Profitable Growth 🧊 Quality Compounders 💵 Dividend Stars 📈 Strong Momentum 📉 Fallen Angels ⚖️ Deeply Undervalued 🔍 Small-Cap Gems 🏰 Moat at a Fair Price 💼 Insider Buying 🎩 Buffett-Style Quality 📚 Peter Lynch GARP 🧮 Greenblatt Magic Formula 🛡️ Graham Defensive

Discover tools

Stock screener Filter by region, size and sector Compare tool Two stocks side by side Fama-French 3-Factor Model Calculator Run the Fama-French 3-factor model in seconds: expected return from the market, size and value factors - free, with formula, betas and an example. Peter Lynch Fair Value Formula & Calculator Apply Peter Lynch's fair value formula in seconds: fair P/E ≈ earnings growth (+ dividend) - free, with formula and example.

Frequently asked questions

Is Ihuman Inc (IH) overvalued or undervalued?
As of Aug 30, 2026, our model estimates a fair value of $1.14 versus a price of $1.22, about −6% upside (fairly valued).
What is the fair value of IH?
Our model-based fair value for Ihuman Inc is $1.14 (as of Aug 30, 2026), built from audited fundamentals. The current price: $1.22.
What is the quality score of IH?
Ihuman Inc has a Quality Score of 60/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the revenue of Ihuman Inc (IH)?
Ihuman Inc reported trailing-twelve-month revenue of about $807M (latest available figure, as of Aug 30, 2026).
What is the net profit margin of IH?
The net profit margin of Ihuman Inc is about 11.8%, meaning it keeps roughly 11.8% of revenue as net income. Based on the latest reported figures.
Does Ihuman Inc pay a dividend?
Ihuman Inc currently shows a dividend yield of about 4.31% relative to its recent price (as of Aug 30, 2026).
Free · no account needed

Watch Ihuman Inc in the live analysis

One click puts Ihuman Inc on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener. You can also try 14 days of Pro there, no card.

Watch for free →

Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.